LENZ
LENZ Therapeutics Inc.
Company Overview
| Mkt Cap | $911.85M | Price | $29.72 |
| Volume | 840.52K | Change | -2.43% |
| P/E Ratio | -18.3 | Open | $30.84 |
| Revenue | -- | Prev Close | $30.46 |
| Net Income | $-49.8M | 52W Range | $16.54 - $50.40 |
| Div Yield | N/A | Target | $53.43 |
| Overall | 38 | Value | 55 |
| Quality | 42 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyLENZ Therapeutics Inc. (LENZ) is a leading diversified company in the business industry, currently trading at $29.72 with a market capitalization of $911.85 million. The stock is in the lower portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows LENZ with a volume of 841K shares. The stock opened up 1.25% from yesterday's close of $30.46. Current analyst estimates project earnings of $-2.62 per share for this year, with next year targeting $-2.51.
LENZ demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for LENZ include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 79.8%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 07:28 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LENZ | $29.72 | -2.4% | 840.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |